04:32 PM EDT, 03/22/2024 (MT Newswires) -- Axonics ( AXNX ) said its shareholders approved its merger agreement with Boston Scientific ( BSX ) .

The medical technology company in January agreed to be acquired by Boston Scientific ( BSX ) for $71 per share in cash for an equity value of roughly $3.7 billion.

Axonics ( AXNX ) said the transaction is expected to close in the first half of this year and remains subject to certain conditions.